Design, Synthesis, Biological and Docking Studies of Novel 6-fluorobenzothiazole Substituted 1,2,4-Triazole Analogues as Prospective Anti-inflammatory Agents.

Document Type : Original Article

Authors

1 Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Vadlamudi, Guntur, A.P., India-522213.

2 Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chowdavaram, Guntur -522019, A. P., India.

3 Sreedattha institute of pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad, RR dist. Telangana, India

4 Joginapally B.R.Pharmacy college Yenkapally, Moinabad, Hyderabad, Telangana 500075

5 Rbvrr Womens College of Pharmacy, Barkatpura.Hyderabad.

6 Department of Pharmaceutical Analysis, CMR College of Pharmacy, Kandlakoya, Medchal, Hyderabad, Telangana, India.

7 Department of Pharmaceutical Sciences, Vignan's Foundation for Sciences, Technology and Research, Vadlamudi, Guntur, A.P-522213.

8 Department of Pharmaceutical Chemistry, College of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India.

9 Department of Pharmaceutics, KITS College of Pharmacy for Women, Divili, Tirupathi (V), Peddapuram (M), Kakinada (Dt)-533 433, Andhra Pradesh.

Abstract

The Part of the body's immunological reaction to an external stimulus is inflammation. It is helpful initially because it starts with the mending process. It is concerning, though, because inflammation has the ability to self-replicate, causing new inflammation to arise in reaction to pre-existing inflammation. In this study, a novel series of 6-Fluoro Benzothiazole substituted 1,2,4-Triazole derivatives were synthesized as prospective anti-inflammatory agents. The newly created substances were examined using mass spectrometry, 1H-NMR, 13C-NMR, and FTIR. First, the compounds underwent rigorous in vivo testing for acute toxicity and anti-inflammatory activity. To further validate these findings, an in silico docking study was carried out against COX-2 (PDB ID: 1pxx). The in vivo results revealed that three compounds-TZ9, TZ2, and TZ1, displayed no acute toxicity and significant anti-inflammatory activity, surpassing the efficacy of the standard drug, diclofenac sodium. Notably, TZ9, which featured diphenyl amino substitution, emerged as the most potent anti-inflammatory agent among the screened compounds. The computational analysis demonstrated that TZ9, and TZ2, exhibited substantial binding affinity, with the highest binding energies (-11.6 and -10.2, Kcal/mol) compared to diclofenac (-8.4 Kcal/mol). This alignment between in vivo and in silico data supported the robust anti-inflammatory potential of these derivatives. According to this work, the anti-inflammatory action of benzothiazole substituted with diphenyl amine, tyrosine, ortho Phenylene diamine and 4-amino benzoic acid at the seventh position is enhanced. The synthesised compounds were also characterised by solubility, TLC, analytical data, IR, 1HNMR, and mass spectrum examinations.

Keywords

Main Subjects



Articles in Press, Accepted Manuscript
Available Online from 21 July 2024
  • Receive Date: 18 March 2024
  • Revise Date: 18 June 2024
  • Accept Date: 19 July 2024